UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH2) with anti-inflammatory activity in the mouse models of colitis

Peptides (New York, N.Y. : 1980), 2018-10, Vol.108, p.34-45

2018

Volltextzugriff (PDF)

Encenicline, an α7 Nicotinic Acetylcholine Receptor Partial Agonist, Reduces Immune Cell Infiltration in the Colon and Improves Experimental Colitis in Mice

The Journal of pharmacology and experimental therapeutics, 2016-01, Vol.356 (1), p.157

2016

Volltextzugriff (PDF)

Novel orally available salvinorin A analog PR-38 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome

The Journal of pharmacology and experimental therapeutics, 2014-07, Vol.350 (1), p.69-78

2014

Volltextzugriff (PDF)

Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)

Journal of Crohn's and colitis, 2014-09, Vol.8 (9), p.998-1009

2014

Volltextzugriff (PDF)

Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice

Naunyn-Schmiedeberg's archives of pharmacology, 2017-10, Vol.390 (10), p.1015-1027

2017

Volltextzugriff (PDF)

Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid‐like fatty acid amides

Neurogastroenterology and motility, 2014-04, Vol.26 (4), p.470-481

2014

Volltextzugriff (PDF)

Salvinorin A analogues PR‐37 and PR‐38 attenuate compound 48/80‐induced itch responses in mice

British journal of pharmacology, 2015-09, Vol.172 (17), p.4331-4341

2015

Volltextzugriff (PDF)

Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea‐predominant IBS

Neurogastroenterology and motility, 2014-11, Vol.26 (11), p.1539-1550

2014

Volltextzugriff (PDF)

FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue‐derived hormone levels in mouse models mimicking constipation‐predominant IBS

Neurogastroenterology and motility, 2018-05, Vol.30 (5), p.e13272-n/a

2018

Volltextzugriff (PDF)

The cannabinoid‐1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice

Neurogastroenterology and motility, 2013-08, Vol.25 (8), p.e550-e559

2013

Volltextzugriff (PDF)

Systemic Administration of Sialorphin Attenuates Experimental Colitis in Mice via Interaction With Mu and Kappa Opioid Receptors

Journal of Crohn's and colitis, 2017-08, Vol.11 (8), p.988-998

2017

Volltextzugriff (PDF)

Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain

International journal of colorectal disease, 2019-02, Vol.34 (2), p.217-227

2019

Volltextzugriff (PDF)

Polyphenol extract from evening primrose pomace alleviates experimental colitis after intracolonic and oral administration in mice

Naunyn-Schmiedeberg's archives of pharmacology, 2014-11, Vol.387 (11), p.1069-1078

2014

Volltextzugriff (PDF)

Calea zacatechichi dichloromethane extract exhibits antidiarrheal and antinociceptive effects in mouse models mimicking irritable bowel syndrome

Naunyn-Schmiedeberg's archives of pharmacology, 2015-10, Vol.388 (10), p.1069-1077

2015

Volltextzugriff (PDF)

High activity of endogenous opioid system protects against gastric damage development in mouse models of gastric mucosal injury

Pharmacological reports, 2019-04, Vol.71 (2), p.218-224

2019

Volltextzugriff (PDF)

Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases

The Journal of pharmacology and experimental therapeutics, 2014-03, Vol.348 (3), p.401-409

2014

Volltextzugriff (PDF)

Nociceptin / orphanin FQ (NOP) receptors as novel potential target in the treatment of gastrointestinal diseases

Current drug targets, 2013-09, Vol.14 (10), p.1203-1209

2013

Volltextzugriff (PDF)

Highly selective CB^sub 2^ receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice

Naunyn-Schmiedeberg's archives of pharmacology, 2017-10, Vol.390 (10), p.1015

2017

Volltextzugriff (PDF)

Young gastroenterologists angle: Friends of the UEG young talent group consensus statement on the structure of young gastroenterology sections

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023-07, Vol.11 (6), p.578-581

2023

Volltextzugriff (PDF)

Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome

Journal of pharmacy and pharmacology, 2015-02, Vol.67 (2), p.244-254

2015

Volltextzugriff (PDF)

Encenicline, an 7 Nicotinic Acetylcholine Receptor Partial Agonist, Reduces Immune Cell Infiltration in the Colon and Improves Experimental Colitis in Mice

The Journal of pharmacology and experimental therapeutics, 2015-12, Vol.356 (1), p.157-169

2015

Volltextzugriff (PDF)

Highly selective CB 2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice

Naunyn-Schmiedeberg's archives of pharmacology, 2017-10, Vol.390 (10), p.1015

2017

Volltextzugriff (PDF)

Cover Image

Neurogastroenterology and motility, 2018-05, Vol.30 (5)

2018

Volltextzugriff (PDF)

FABP 4 blocker attenuates colonic hypomotility and modulates white adipose tissue‐derived hormone levels in mouse models mimicking constipation‐predominant IBS

Neurogastroenterology and motility, 2018-05, Vol.30 (5)

2018

Volltextzugriff (PDF)

Severe eye injury in an 11-year-old child during threshing--A case report

Annals of Agricultural and Environmental Medicine, 2006, Vol.13 (1), p.181-183

2006

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(47)
Buchkapitel
(2)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH2) with anti-inflammatory activity in the mouse models of colitis

Encenicline, an α7 Nicotinic Acetylcholine Receptor Partial Agonist, Reduces Immune Cell Infiltration in the Colon and Improves Experimental Colitis in Mice

Novel orally available salvinorin A analog PR-38 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome

Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)

Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice

Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid‐like fatty acid amides

Salvinorin A analogues PR‐37 and PR‐38 attenuate compound 48/80‐induced itch responses in mice

Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea‐predominant IBS

FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue‐derived hormone levels in mouse models mimicking constipation‐predominant IBS

The cannabinoid‐1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice

Systemic Administration of Sialorphin Attenuates Experimental Colitis in Mice via Interaction With Mu and Kappa Opioid Receptors

Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain

Polyphenol extract from evening primrose pomace alleviates experimental colitis after intracolonic and oral administration in mice

Calea zacatechichi dichloromethane extract exhibits antidiarrheal and antinociceptive effects in mouse models mimicking irritable bowel syndrome

High activity of endogenous opioid system protects against gastric damage development in mouse models of gastric mucosal injury

Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases

Nociceptin / orphanin FQ (NOP) receptors as novel potential target in the treatment of gastrointestinal diseases

Highly selective CB^sub 2^ receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice

Young gastroenterologists angle: Friends of the UEG young talent group consensus statement on the structure of young gastroenterology sections

Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome

Encenicline, an 7 Nicotinic Acetylcholine Receptor Partial Agonist, Reduces Immune Cell Infiltration in the Colon and Improves Experimental Colitis in Mice

Highly selective CB 2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice

Cover Image

FABP 4 blocker attenuates colonic hypomotility and modulates white adipose tissue‐derived hormone levels in mouse models mimicking constipation‐predominant IBS

Severe eye injury in an 11-year-old child during threshing--A case report

Suchergebnisse filtern